Biotech

Puma Biotechnology Inc (NYSE:PBYI) shares rose 17.22% on Friday to $26.21 as 1.75 million shares traded hands compared to an average trading volume of  778,890 shares. Puma Biotechnology Inc (NYSE:PBYI) reported its quarterly earnings data earlier in the week, showing a loss of $1.28 per share versus expectations of a $1.99...

Concert Pharmaceuticals Inc (NASDAQ:CNCE) shares closed 9.87% higher on Friday to $11.13, still within the lower part of its 52-week range of $9.81 to $25.04. Concert Pharmaceuticals Inc (NASDAQ:CNCE) shares dropped sharply at the start of May even after the company reported its CTP-543 drug for the treatment of alopecia...

ChemoCentryx Inc (NASDAQ:CCXI) shares continued to trade higher and closed 53.58% up to $4.60 on Wednesday, as the company granted marketing rights for CCX168 to Vifor Pharma. ChemoCentryx Inc (NASDAQ:CCXI) has been developing CCX168 for the treatment of conditions including but not limited to anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This has...

Cytori Therapeutics Inc (NASDAQ:CYTX) shares received a strong boost to $3.38 after the European Commission granted orphan drug status to the company's Cytori Cell Therapy® formulations. Cytori Therapeutics Inc (NASDAQ:CYTX) is a biotechnology company involved in the development of treatments and devices for a range of disorders using cells as a key...

Argos Therapeutics Inc (NASDAQ:ARGS) shares were up 18.12% to $6.91 in Monday's New York session and an additional 2.17% in after-hours trading to $7.06. Argos Therapeutics Inc (NASDAQ:ARGS) shares hit a high of $7.64 on Monday before sliding lower, offering an opportunity to catch a short-term pullback. Prior to the early...